Arcturus Therapeutics Holdings Inc
ARCT
Get informed when a big investor buys or sells
+ FollowMarket Cap$195.55M
Close$
$-6.16
184.7% downside
Current Fair Value
184.7% downsideOvervalued by 184.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $195.55 Million |
|---|---|
| Enterprise Value | $11.47 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.4 |
| Beta | 2.35 |
| Outstanding Shares | 28,421,000 |
Return
| Return on Equity | -26.01% |
|---|---|
| Return on Assets | -20.28% |
| Return on Invested Capital | -41.14% |
Valuation & Multiples
| P/E Ratio | -2.43 |
|---|---|
| PEG | 2.14 |
| Price to Sales | 7.28 |
| Price to Book Ratio | 1.21 |
| Enterprise Value to Revenue | 0.26 |
| Enterprise Value to EBIT | -0.13 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 2.38 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 11, 2026
EPS Estimate
$-1.01
Average shareholder expectationRevenue Estimate
$6.30 M
Average shareholder expectationNext Earnings Call
Expected Date
August 10, 2026
EPS Estimate
$-1.00
Average shareholder expectationRevenue Estimate
$3.19 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.7979▲ 21.28% |
|---|---|
| Total Calls | 225,221▼ 28.19% |
| Total Puts | 179,700▼ 2.07% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 88.69%▲ 1.53% |
|---|---|
| Total Invested | $187.31M▲ 27.98% |
| Investors Holding | 130▼ 2.00% |
ESG Score
No data